Steve E. Newman
Impact in
-
- Inhalation and Respiratory Drug Delivery
- Respiratory and Cough-Related Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
Papers in
-
- Inhalation and Respiratory Drug Delivery 7
- Infection Control and Ventilation 1
-
- Asthma and respiratory diseases 4
- Diet and metabolism studies 1
- Co-authors
- Gary R. Pitcairn (3 shared papers)Demetri Pavia (1 shared paper)Ruediger Nave (1 shared paper)Andrew G. Salmon (1 shared paper)Anton Drollmann (1 shared paper)Jolyon P. Mitchell (1 shared paper)Hak‐Kim Chan (1 shared paper)John Bell (1 shared paper)
- Journals
- Expert Opinion on Drug Delivery (2 papers)Journal of Aerosol Medicine and Pulmonary Drug Delivery (1 paper)Respiratory Medicine (1 paper)International Journal of Pharmaceutics (1 paper)Ecological Indicators (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Steve E. Newman
16 papers receiving 528 citations
Peers
Comparison fields: 5 of 80
- Pulmonary and Respiratory Medicine 416
- Pharmaceutical Science 77
- Physiology 184
- Ecological Modeling 28
- Food Science 42
Countries citing papers authored by Steve E. Newman
This map shows the geographic impact of Steve E. Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve E. Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve E. Newman more than expected).
Fields of papers citing papers by Steve E. Newman
This network shows the impact of papers produced by Steve E. Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve E. Newman. The network helps show where Steve E. Newman may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve E. Newman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 125 | |
| 2 | 2005 | 122 | |
| 3 | 2007 | 88 | |
| 4 | 2019 | 61 | |
| 5 | 2007 | 49 | |
| 6 | 2010 | 46 | |
| 7 | 2006 | 36 | |
| 8 | 2013 | 27 | |
| 9 | 2012 | 12 | |
| 10 | 2006 | 3 | |
| 11 | Clues to the Structural History of the Rankin Trend, from 3-D Seismic Data | 1994 | 3 |
| 12 | 2004 | 3 | |
| 13 | 2020 | 2 | |
| 14 | 2011 | 1 | |
| 15 | TARGETING AN INHALED ERYTHROPOIETIN-Fc FUSION PROTEIN (Epo-Fc) TO THE HUMAN LARGE CENTRAL AIRWAYS | 2002 | 1 |
| 16 | 2020 | 1 |
About Steve E. Newman
Steve E. Newman is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Food Science, Ecological Modeling and Pharmaceutical Science, having authored 16 papers that have together received 580 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (7 papers), Asthma and respiratory diseases (4 papers), Food Safety and Hygiene (2 papers), Wildlife Ecology and Conservation (1 paper), Refrigeration and Air Conditioning Technologies (1 paper), Reservoir Engineering and Simulation Methods (1 paper), Infection Control and Ventilation (1 paper) and Diet and metabolism studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (416 citations), Pharmaceutical Science (77 citations), Physiology (184 citations), Ecological Modeling (28 citations) and Food Science (42 citations). Steve E. Newman has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Gary R. Pitcairn, Demetri Pavia, Ruediger Nave, Andrew G. Salmon, Anton Drollmann, Jolyon P. Mitchell, Hak‐Kim Chan, John Bell, G. Scheuch and John S. Fleming. Their work appears in journals such as Expert Opinion on Drug Delivery, Journal of Aerosol Medicine and Pulmonary Drug Delivery, Respiratory Medicine, International Journal of Pharmaceutics and Ecological Indicators.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.